Mukherjee S, Manna A, Bhattacharjee P, Mazumdar M, Saha S, Chakraborty S, Guha D, Adhikary A, Jana D, Gorain M, Mukherjee S A, Kundu G C, Sarkar D K, Das T
Division of Molecular Medicine, Bose Institute, P-1/12, Calcutta Improvement Trust Scheme VII M, Kolkata, India.
Department of Surgery, SSKM Hospital, Kolkata, India.
Oncogene. 2016 Sep 15;35(37):4937-48. doi: 10.1038/onc.2016.26. Epub 2016 Feb 29.
Although the role of metastatic cancer stem cells (mCSCs) in tumor progression has been well documented, our study reveals a hitherto unidentified role of tumorigenic intrinsic CSCs (iCSCs) in breast cancer metastasis. We show that unlike highly migratory mCSCs residing in the breast tumor disseminating/peripheral regions, iCSCs populate the inner mass of the tumor and are non-migratory. However iCSCs, via paracrine signaling, induce conversion of non-stem cancer cells to CSCs that (i) are identical to the previously reported mCSCs, and (ii) in contrast to iCSCs, express chemokine receptor, chemokine (C-X-C motif) receptor 4 (CXCR4), which is crucial for their metastatic potential. These mCSCs also demonstrate high in vivo tumorigenicity. Physical non-participation of iCSCs in metastasis is further validated in vivo, where only mCSCs are found to exist in the metastatic sites, lymph nodes and bone marrow, whereas the primary tumor retains both iCSCs and mCSCs. However, iCSCs ensure metastasis since their presence is crucial for deliverance of highly metastatic CXCR4(+) mCSCs to the migrating fraction of cells. Cumulatively, these results unveil a novel role of iCSCs in breast cancer metastasis as parental regulators of CXCR4(+) mCSCs, and highlight the therapeutic requisite of targeting iCSCs, but not CXCR4(+) mCSCs, to restrain breast cancer metastasis from the root by inhibiting the generation of mCSCs from iCSCs. Considering the pivotal role of iCSCs in tumor metastasis, the possibility of metastasis to be a 'stem cell phenomena' is suggested.
尽管转移性癌症干细胞(mCSCs)在肿瘤进展中的作用已有充分记载,但我们的研究揭示了致瘤性内在癌症干细胞(iCSCs)在乳腺癌转移中迄今未被发现的作用。我们发现,与存在于乳腺肿瘤播散/外周区域的高迁移性mCSCs不同,iCSCs聚集在肿瘤内部,且不具有迁移性。然而,iCSCs通过旁分泌信号诱导非干细胞癌细胞转化为CSCs,这些CSCs(i)与先前报道的mCSCs相同,(ii)与iCSCs相反,表达趋化因子受体、趋化因子(C-X-C基序)受体4(CXCR4),这对其转移潜能至关重要。这些mCSCs在体内也表现出高致瘤性。iCSCs在转移过程中的实际不参与在体内进一步得到验证,在转移部位、淋巴结和骨髓中仅发现存在mCSCs,而原发性肿瘤同时保留iCSCs和mCSCs。然而,iCSCs确保了转移,因为它们的存在对于将高转移性CXCR4(+) mCSCs递送至迁移细胞部分至关重要。总的来说,这些结果揭示了iCSCs在乳腺癌转移中作为CXCR4(+) mCSCs的亲本调节因子的新作用,并强调了靶向iCSCs而非CXCR4(+) mCSCs以通过抑制从iCSCs产生mCSCs从根源上抑制乳腺癌转移的治疗必要性。考虑到iCSCs在肿瘤转移中的关键作用,提示转移可能是一种“干细胞现象”。